Proptech Breakthrough Awards PALO ALTO, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”) an award-winning leader in AI Surveillance and Remote Guarding, today announced that its Alpha™ platform—developed in partnership with Flex Security, a division of RVMP®—has been named “Project Management Solution of the Year” for construction in the 5th Annual PropTech Breakthrough Awards. The program, conducted by PropTech Breakthrough, a leading independent market intelligence organization, recognizes the world's most innovative real estate technology companies and solutions.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Celanese Corporation (“Celanese” or the “Company”) (NYSE: CE) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CELANESE CORPORATION (CE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On November 4, 2024, after market hours, Celanese reported its thir.

LOS ANGELES, Aug. 14, 2025 (GLOBE NEWSWIRE) -- LiveOne (Nasdaq: LVO), an award-winning, creator-first music, entertainment, and technology platform, today announced that it has purchased Bitcoin as part of the company's previously announced crypto long-term treasury yield management strategy.

AMZN's ad revenues gain 23% in Q2 2025 to $15.69B, fueled by AI, retail media, CTV growth and Prime Video's global ad rollout.

Sarepta sells $174M in Arrowhead shares to fund a $100M milestone payment as part of its RNAi drug collaboration.

CMG is banking on new hits like Honey Chicken and Adobo Ranch to revive comp sales after a sluggish start to 2025.

Cellectar Biosciences, Inc. (NASDAQ:CLRB ) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Company Participants Chad J. Kolean - VP, CFO & Secretary James V.

Is Bitcoin Depot's 183% profit surge, kiosk growth and discounted valuation a signal to buy the stock now? Let's check it out.

TPR's posts robust Q4 results as Coach fuels growth, digital sales climb and global markets deliver strong gains.

ARAY stock down after Q4 earnings miss estimates, with product sales hit by tariffs and regional demand softness.

U.S. equities were lower at midday as wholesale inflation rose more than expected in July. The Dow Jones Industrial Average, S&P 500, and Nasdaq were all down.

CCL Industries Inc. (OTCPK:CCDBF) Q2 2025 Earnings Conference Call August 14, 2025 7:30 AM ET Company Participants Geoffrey T. Martin - President, CEO & Director Sean P.

LOS ANGELES, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

ALLO posts a narrower second-quarter 2025 loss. The company advances multiple CAR T programs targeting cancer and autoimmune diseases.

FI's stablecoin launch with PayPal and a solid growth outlook show promise, but profitability and competition pose challenges.

SAN ANTONIO , Aug. 14, 2025 /PRNewswire/ -- Corporate law firm Elder Bray & Bankler PC recently advised FGI Group, Inc. on its sale of Dynamic Systems to Quanta Services, Inc. (NYSE: PWR) for an upfront purchase price of $1.35 billion, and a potential earnout of up to $216 million. The upfront purchase price was paid in a mix of cash and publicly-traded stock of Quanta.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Sarepta To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Sarepta between June 22, 2023 and June 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 14, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sarepta Therapeutics, Inc. ("Sarepta" or the …

Apellis Pharmaceuticals: Restart Of Growth Story After Empaveli's New Approval

Does C's 61.2% stock surge, fueled by strategic exits, cost cuts and gains in wealth and investment banking, make it worth investing in? Let us find out.

CCL plans strategic ship additions and upgrades to elevate guest experience and strengthen its market position.